BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
3976
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.33M | ﹤0.01% |
679,323
-4,016
| -0.6% | -$19.5K |
|
3977
Shore Bancshares
SHBI
$799M
| $3.32M | ﹤0.01% |
186,989
-3,387
| -2% | -$58.8K |
|
|
PNNT
3978
Pennant Park Investment Corp
PNNT
$249M
| $3.31M | ﹤0.01% |
510,310
+93,585
| +22% | +$615K |
|
3979
iShares US Industrials ETF
IYJ
$1.96B
| $3.3M | ﹤0.01% |
+30,831
| New | +$3.46M |
|
|
LTCHW
3980
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
| $3.3M | ﹤0.01% |
1,000,000
| – | – |
|
3981
Quad
QUAD
$506M
| $3.3M | ﹤0.01% |
776,007
+17,475
| +2% | +$72.2K |
|
3982
Immersion
IMMR
$248M
| $3.29M | ﹤0.01% |
481,526
+99,805
| +26% | +$745K |
|
|
AVEO
3983
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $3.29M | ﹤0.01% |
532,605
+53,813
| +11% | +$322K |
|
3984
Hurco Companies Inc
HURC
$143M
| $3.29M | ﹤0.01% |
101,884
-4,657
| -4% | -$155K |
|
3985
Annovis Bio
ANVS
$76.1M
| $3.28M | ﹤0.01% |
103,330
+2,333
| +2% | +$134K |
|
|
FUSN
3986
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.28M | ﹤0.01% |
414,256
-56,047
| -12% | -$472K |
|
|
IMPL
3987
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $3.27M | ﹤0.01% |
268,730
+17,667
| +7% | +$256K |
|
3988
NextDecade
NEXT
$1.8B
| $3.26M | ﹤0.01% |
1,173,347
-175,018
| -13% | -$552K |
|
|
PTR
3989
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $3.26M | ﹤0.01% |
69,714
-241,257
| -78% | -$10.7M |
|
|
BELFB
3990
Bel Fuse Inc Class B
BELFB
$4.13B
| $3.26M | ﹤0.01% |
262,191
-867,896
| -77% | -$11.6M |
|
|
MITT
3991
TPG Mortgage Investment Trust
MITT
$214M
| $3.25M | ﹤0.01% |
284,335
-2,798
| -1% | -$30.6K |
|
3992
XWELL
XWEL
$8.53M
| $3.24M | ﹤0.01% |
110,347
+8,489
| +8% | +$273K |
|
3993
Consumer Portfolio Services
CPSS
$208M
| $3.23M | ﹤0.01% |
556,566
+1,304
| +0.2% | +$6.88K |
|
3994
NLI Holdings
NL
$319M
| $3.23M | ﹤0.01% |
560,369
+24,370
| +5% | +$153K |
|
3995
Alico
ALCO
$304M
| $3.22M | ﹤0.01% |
94,081
-3,885
| -4% | -$140K |
|
3996
Value Line
VALU
$341M
| $3.2M | ﹤0.01% |
93,545
-6,626
| -7% | -$220K |
|
3997
First Business Financial Services
FBIZ
$601M
| $3.19M | ﹤0.01% |
111,244
+23,773
| +27% | +$657K |
|
|
IIN
3998
DELISTED
IntriCon Corporation
IIN
| $3.19M | ﹤0.01% |
175,762
-1,709
| -1% | -$36.8K |
|
3999
ZIM Integrated Shipping Services
ZIM
$3.23B
| $3.19M | ﹤0.01% |
+62,880
| New | +$2.94M |
|
|
IBCE
4000
DELISTED
iShares iBonds Mar 2023 Term Corporate ex-Financials ETF
IBCE
| $3.19M | ﹤0.01% |
129,000
| – | – |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.